Genmab maintains 2026 revenue guidance, forecasts 19% growth at midpoint
Genmab maintains 2026 revenue guidance, forecasts 19% growth at midpoint Genmab maintained 2026
Genmab maintains 2026 revenue guidance, forecasts 19% growth at midpoint Genmab maintained 2026